University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Masters Theses

Dissertations and Theses

November 2015

In Vitro Screening for Small-Molecule Kinase Inhibitors of TestisSpecific Serine Kinase 1 (TSSK1), a Potential Target for Male
Contraception
Julie Majka
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/masters_theses_2

Recommended Citation
Majka, Julie, "In Vitro Screening for Small-Molecule Kinase Inhibitors of Testis-Specific Serine Kinase 1
(TSSK1), a Potential Target for Male Contraception" (2015). Masters Theses. 284.
https://doi.org/10.7275/7205169 https://scholarworks.umass.edu/masters_theses_2/284

This Open Access Thesis is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

IN VITRO SCREENING FOR SMALL-MOLECULE KINASE INHIBITORS OF TESTISSPECIFIC SERINE KINASE 1 (TSSK1), A POTENTIAL TARGET FOR MALE
CONTRACEPTION

A Thesis Presented
by
JULIE KATHERINE MAJKA

Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
MASTER OF SCIENCE
September 2015
Animal Biotechnology and Biomedical Sciences,
Veterinary and Animal Science Department

“IN VITRO SCREENING FOR SMALL-MOLECULE KINASE INHIBITORS OF TESTISSPECIFIC SERINE KINASE 1 (TSSK1), A POTENTIAL TARGET FOR MALE
CONTRACEPTION”

A Thesis Presented
by
JULIE KATHERINE MAJKA

Approved as to style and content by:

_______________________________
Ana Maria Salicioni, Chair

_______________________________
Rafael Fissore, Member

_______________________________
Katherine Beltaire, Member

_______________________________
Rafael Fissore, Department Head
Veterinary and Animal Sciences Department

DEDICATION
To Drs. Bill Beal and James Knight – two professors who told me to never do anything in
the field of reproductive biology because I “would never be any good at it.”
To Dr. Cynthia Wood – standing in front of my Ansci seminar class you took a poll of
what we wanted to be when we grew up. You said “54 of you want to be veterinarians;
maybe two or three of you will be. Everyone else, find a new dream.” I’m glad I ignored
your advice; this thesis is a testament to pursuing your dream even if you’re told that
you’ll never achieve it.
To my family and my Matthew – a continuous supply of support, encouragement, and
love, –sometimes tough love! –trips to Cindy’s, homemade meals, chauffeuring postknee surgery, and everything in between made this possible. Thank you for all you’ve
done for the past two years.

ACKNOWLEDGEMENTS
I would like to both acknowledge and thank Dr. Ana Maria Salicioni and Dr.
Pablo Visconti for allowing me this opportunity to learn and grow as a scientist. Thanks
to your dedication and patience, I have gained a great deal of knowledge and have been
able to achieve my goal of going to veterinary school.
I would like to thank my committee: Dr. Ana Maria Salicioni, Dr. Rafael Fissore,
and Dr. Katherine Beltaire for their willingness to be members of my committee and
make time in their schedules for me to complete this thesis.
A special thanks goes to Dr. Maria Gracia Gervasi, without whom I probably
would have given up a long time ago. She has the patience of a saint and has been a
wonderful teacher, mentor, and friend to me for the past two years. Maria’s insistence of
thoroughness taught me how to be critical of my work –an invaluable lesson in science,
and in life. Her positivity and constant encouragement were sometimes the only things
pushing me through this program.
My fellow lab members: Antonio, Felipe, Bidur, and our undergraduate students –
thank you all for the help you provided to train me, allowing me to gain experience and
ask questions, opening the liquid nitrogen tank, and the camaraderie you’ve given.
The graduate students of the Veterinary and Animal Sciences department for
providing support throughout this degree, for lending an ear when I needed to talk, or
work through an experiment or assignment, and for providing guidance when needed.
Thank you especially to Margarita, who was my sounding board and a huge support
while here at school and while at work. Working six days a week would have been
miserable without you!

iv

All of the members of the VASCI department who we would be lost without:
Mary Schneider for making sure I always had my paperwork in order and who can
answer nearly any question you could ever have, Dr. Lisa Minter and Dr. Cynthia
Baldwin for acting as our graduate program directors, members of the business office
who were always there with a smile and an answer, and to all the professors who are so
dedicated to helping students achieve their goals.

v

ABSTRACT
IN VITRO SCREENING FOR SMALL-MOLECULE KINASE INHIBITORS OF TESTIS-SPECIFIC
SERINE KINASE 1 (TSSK1), A POTENTIAL TARGET FOR MALE CONTRACEPTION
SEPTEMBER 2015
JULIE K. MAJKA, B.S. VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST
Directed by: Dr. Ana Maria Salicioni
Despite the availability of a range of contraceptive methods, over 50% of
pregnancies are unintended worldwide (~1,000,000/day). Male contraception remains an
important area of research. Recent acceptability studies indicate that a high percentage of
men would be willing to use a male contraceptive pill. Several non-hormonal targets for a
male-based contraceptive pill have been brought to light recently including the testisspecific serine kinase (TSSK) family, which belongs to the AMPK kinase branch in the
CAMK group. The finding that TSSK family members are postmeiotically expressed in
male germ cells, together with the infertile phenotype found in both Tssk1/2 and Tssk6
mouse knock-out models, has led to the proposal that TSSKs play an important role in
sperm function, making them excellent targets for drug design of novel male
contraceptives.
This research is aimed to the identification of potent, specific inhibitors for
TSSK1 activity for the development of novel male contraceptive pills through the use of
mice as an experimental model. Our hypothesis is that a single kinase inhibitor can
specifically inhibit TSSK’s kinase activity without interfering with other sperm functions,
or other tissue types. In this study, we have assessed the enzyme properties of
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recombinant human TSSK1 by application of a homogeneous, non-radioactive enzyme
activity assay and mid-throughput screening of kinase inhibitors that block TSSK1
activity. Some of these inhibitors have proven to greatly reduce the activity of TSSK1
overall, but lack the specificity desired to be plausible for drug design.
In parallel, our efforts are directed towards developing a functional in vivo assay
using both CD1 and acrosin-GFP-transgenic mice (expressing Acr-GFP in the acrosome)
based on our finding that TSSK1 is localized in the sperm acrosome, which points to a
potential role of TSSKs in sperm acrosome reaction.
The anticipated outcome of this research is to ultimately develop a reversible,
non-hormonal male contraceptive. Our findings may also set the basis for studies on
human sperm function towards a better understanding of male reproductive physiology
and mechanisms of male infertility.
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CHAPTER 1
INTRODUCTION AND MATERIALS & METHODS
1.1 Introduction
Since the 1950’s, women have been the target demographic for developing
contraceptive products, placing the majority of the fertility decisions with the female.
However, men play an undeniable role in procreation, and deserve an equal opportunity
for contraceptive options.
Nearly 37-50% of pregnancies worldwide are unintended (Mosher, Jones et al.
2012), which demonstrates the current need for additional forms of contraception (Fig.
1). Men only have three options in terms of pregnancy prevention: condoms, withdrawal,
or vasectomy. Condoms are easily reversed and 98% effective if used correctly, but has a
failure rate of up to 82%, according to the Center for Disease Control. Withdrawal prior
to ejaculation is a non-permanent option, but only ~72% effective. The final option is a
vasectomy, which is nearly 100% effective, but is a surgical procedure that includes the
ligation of the vas deferens, thus preventing ejaculation of spermatozoa. However, this
procedure is not easily reversed (Control 2015). Evidently, there is a serious lack of male
contraceptive options available; however there are several potential sources for
alternative contraceptive development and research. Currently there are several targets
being studied worldwide that are potential targets for male contraceptives. One such
study is of a physical barrier known as “Reversible inhibition of sperm under guidance
(RISUG)” in India, where it was developed, or as Vasalgel in the United States (Lohiya,
Alam et al. 2014). This polymer is injected directly into the vas deferens and can later be
reversed by injecting a dissolving agent. RISUG is currently in Phase III trials in India.
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Another area of interest for targets of male contraceptives is focused on hormonal targets;
gestagens produced from either testosterone or progesterone derivatives, are being
investigated, some having reached clinical trials (Nieschlag 2010, Dorman and Bishai
2012). Other targets are non-hormonal: epididymal proteins, opioids, miRNAs, plant
extracts, heat/ultrasound treatment, among others (Garside 2013, Kogan and Wald 2014,
Murdoch and Goldberg 2014). In particular, one such area under active investigation is
on testis-specific protein kinases, which is the main focus of research in our laboratory.
Because sperm undergoes a number of changes between ejaculation and
fertilization, sperm-specific proteins are ideal targets for contraception. When the sperm
enters the female reproductive tract, it undergoes a process known as “capacitation.”
Capacitation includes the acquisition of hyperactive motility (Yanagimachi 1981, Suarez,
Katz et al. 1983) and the ability to experience the acrosome reaction – an exocytotic
process that allows penetration of the zona pellucida by the sperm cell (Dan 1952). These
activation-type steps and physiological changes to the sperm are required for oocyte
fertilization (Chang 1951, Visconti 2009). Figure 3 shows the accepted model on the
series of biochemical steps which sperm undergoes during capacitation.
Protein kinases are found throughout humans and animals; their role lies in cell
regulation. Typically kinases phosphorylate some aspect of a protein. This
phosphorylation allows the protein kinase to orchestrate numerous cellular functions,
protein localization, and cell cycle activities. Kinases are protein-specific so they are
grouped in families; these families share similar sequences and catalytic domains. One
subgroup of kinases are those that phosphorylate serine and threonine residues
((Manning, Whyte et al. 2002) and references therein).
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The Testis-Specific Serine Kinases (TSSKs) belong to a family of kinases with a
major role proposed in spermatogenesis (Li, Sosnik et al. 2011). This group of
serine/threonine kinases is part of the 5’ adenosine-monophosphate activated kinase
(AMPK) branch in the calcium/calmodulin-dependent kinase (CAMK) group (Fig. 2) and
lends itself to potentially be a non-hormonal target for a male contraceptive pill via
inhibition of TSSKs (Salicioni 2012). The benefit of these kinases lies within its name:
testis-specific. Being specific to the testis allows for research in this particular area
without much concern for the effect of a kinase inhibitor on other tissues. It is known that
members of the TSSK family are expressed postmeiotically in mature male germ cells
(Hao, Jha et al. 2004, Li, Sosnik et al. 2011). It has been shown that TSSK1 is localized
to the head, specifically the acrosomal region, of the mature sperm, as well as the
flagellum (Li, Sosnik et al. 2011) (Fig. 4). Lastly, It is also known that the TSSK1/2
knockout (Xu, Hao et al. 2008, Shang, Baarends et al. 2010) and the TSSK6 knockout
(Spiridonov, Wong et al. 2005) phenotypes render male mice infertile (Xu, Hao et al.
2008, Shang, Baarends et al. 2010), suggesting that the TSSK family plays a major role
in male fertility and could be a target for specific inhibitors leading to a male
contraceptive pill (Li, Sosnik et al. 2011).
One of our lab’s research goals is to find a specific inhibitor of TSSKs that would
suppress their activity to a level that would render the kinase ineffective. Knowledge of
TSSKs’ position on the murine and human kinome led to the notion that an AMPK
inhibitor may be suitable for the role of suppressing TSSK activity. AMPK is a
heterotrimeric protein kinase comprised of three subunits: α, β, and γ, with α being the
catalytic subunit (Hardie 2015). As discussed previously, TSSKs are found on the AMPK
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branch of the kinome. AMPK acts as an ATP sensor within the cell, maintaining energy
balance via stimulation of catabolic pathways and inhibition of anabolic pathways (Liu,
Chhipa et al. 2014, Nguyen, Alves et al. 2014). There exists an AMPK inhibitor,
Compound C (CC), –also known as “dorsomorphin” and/or “BML-275”– that is
selective, and is a competitive inhibitor at ATP-binding sites (Nguyen, Alves et al. 2014).
Based on the literature, especially Nguyen et al (2014) and de Llera et al (2012) (Hurtado
de Llera, Martin-Hidalgo et al. 2012), it has been proposed that CC has a significant
effect on sperm in a number of other species, including humans.
Our research looks into the biochemical regulation of mouse TSSKs and its role
in the capacitation process and therefore, their potential for a non-hormonal target for
contraception. By using a variety of experimental conditions, the objective of our current
investigation is to find a selective inhibitor of TSSKs, using TSSK1 as a model kinase,
which can be used in an easily reversible, oral contraceptive for men, thus providing
another option for men to choose from when considering contraceptive alternatives.
1.2 Materials & Methods
1.2.1 Aim 1 Materials
1.2.1.1 ADP-Glo™ kit
The ADP-Glo™ kit was purchased from Promega Corporation (Madison, WI)
and includes Ultra Pure ATP and ADP, Glo reagent, and the detection agent
(luciferase/luciferin). 96- and 384-well plates were purchased from VWR Scientific
(Radnor, PA). All reactions were performed in a kinase buffer consisting of a Tris-HCl
mixture (Trizma base from Sigma-Aldrich, St. Louis, MO and HCl from Fisher,
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Waltham, MA), at a pH of 7.4, MgCl2 (Sigma-Aldrich), bovine serum albumin (BSA)
from Sigma-Aldrich, and MilliQ water.
1.2.1.2 Kinases and Substrates
Human recombinant TSSK1 was purchased through Invitrogen (Carlsbad, CA)
and was the kinase used for all kinase assays. Two substrates were used for the
standardization of the kinase assay: myelin basic protein peptide (MBPp) and AMARA.
MBPp was purchased through Sigma-Aldrich, and the AMARA substrate was purchased
via AnaSpec, Inc., (Fremont, CA).
1.2.1.3 Inhibitors
To observe TSSK1 inhibition, several inhibitors were used: Staurosporine, H7,
NMPP1, Roscovitine, Kenpaullone, SU6656, H89, SKI 606, and Compound C.
Staurosporine and Roscovitine were purchased from LC Labs (Woburn, MA). NMPP1,
Kenpaullone, H89, and SKI 606 were purchased from Cayman Chemical (Ann Arbor,
MI). H7 was purchased from Tocris Bioscience (Bristol, UK). SU6656 was purchased
from Sigma-Aldrich. Compound C was purchased from Enzo Life Sciences
(Farmingdale, NY). DMSO was required for preparation of stock solutions (typically
10mM) of several of these inhibitors, including Compound C; thus DMSO (at the
corresponding percentage in final solutions) was used as the vehicle control.
1.2.1.4 Equipment and Data Analysis
Incubation of kinase reactions was performed in an Eppendorf Thermomixer® R
at 37°C. Following completion of the assay, the plate was read in a POLARstar Omega
plate reader by BMG Labtech. The POLARstar machine was set to read plates at an
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interval of 0.10 seconds at a gain of 2500-3600 at 80%. Data was analyzed using both
Microsoft Excel and SigmaPlot (by Systat Software Inc.).
1.2.2 Aim 1 Methods
1.2.2.1 Kinase Assay
The initial step in running the assay was preparing the buffer; to do so, Tris-HCl
at 40mM and pH of 7.4 was combined with 20mM MgCl2, BSA at 0.1mg/ml, and MilliQ
water. This buffer was used throughout the assay to prepare the other reagents. The ATP
was prepared at varying concentrations between 0-1mM using the buffer to dilute the
ATP as needed. The substrates (AMARA and MBPp) were prepared at concentrations
ranging from 0-100μM using buffer as a reconstitution agent. The kinase (hrTSSK1) was
prepared at different concentrations ranging from 0-300ng in the previously described
buffer. In some cases, the experimental reagent was prepared by using serial dilution.
In the 96-well plate assays, we decided to have a total quantity of 25μl per kinase
reaction. In 384-well plate assays, only a total of 5μl of reagents were included in each
well.
When conducting an assay, the reagents were prepared and put into the
appropriately sized well plate at a ratio of 1:1:1:2 (buffer, ATP, substrate, kinase,
respectively, and +/- inhibitor), and incubated at 37°C for 30 minutes in the Eppendorf
Thermomixer® R. Next, the Glo reagent was added; the ratio was 1:1:2, indicating
amounts for the reaction, Glo reagent, and detection agent, respectively. For a 96-well
plate reaction that carried a volume of 25μl of kinase reaction, 25μl of Glo reagent was
added to the reaction following the incubation period. The reaction was allowed to
proceed at room temperature for 40 minutes. After this second incubation, 50μl of
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detection reagent was added to each reaction and incubated away from light for 60
minutes at room temperature. The plate was then read in the POLARstar Omega plate
reader, which generated the number of relative luminescence units (RLUs), a direct
indicator of ADP production and, thus, of kinase activity. Figure 5 provides a principle of
the ADP-Glo™ kinase reaction and detection, and a summary of the reactions that
occurred during this process.
1.2.3 Aim 2 Materials
1.2.3.1 Animals
CD1 retired male breeder mice were purchased from Charles River Laboratories
(Wilmington, MA). Transgenic Acr-GFP male and female mice were donated from Dr.
G. Gerton (UPenn, Philadelphia, PA), who had originally obtained them from M. Okabe
(Okabe, Ikawa et al. 1997, Ikawa, Yamada et al. 1999, Nakanishi, Ikawa et al. 1999,
Ventela, Mulari et al. 2000, Hasuwa, Muro et al. 2010). All mice were maintained and
housed for up to two weeks in a monitored facility at the University of Massachusetts,
Amherst; all animal protocols were reviewed and approved by the University of
Massachusetts Institutional Animal Care and Use Committee.
1.2.3.2 Media and Inhibitors
Protein extraction of mouse sperm cells was performed in modified Toyoda–
Yokoyama–Hosi (mTYH) media (Tateno, Krapf et al. 2013) prepared and stored at 4°C
within one month of use. The media was prepared with the following components (in
millimolar concentrations, from Sigma-Aldrich): 119.37 NaCl, 4.7 KCl, 1.71
CaCl22H2O, 1.2 KH2PO4, 1.2 MgSO47H2O, 20 Hepes, 5.56 glucose, 0.51 sodium
pyruvate, 10μg/mL gentamicin, and 0.0006% phenol red. To prepare capacitating (Cap)
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media using mTYH, 10mg/ml of BSA (Sigma-Aldrich) and 30mM of HCO-3 (SigmaAldrich) was added to the media on the day of the assay. Noncapacitating (NC) media did
not have the BSA or HCO-3 additives. The pH of the media was adjusted using
200mg/mL NaOH (Sigma-Aldrich) to pH 7.2-7.4 (typically falling between 7.32-7.38).
M2 media was purchased from Sigma-Aldrich and used during IVF.
The AMPK inhibitor Compound C was prepared in DMSO at 10mM from Enzo
Life Sciences (Farmingdale, NY) and was used during subsequent capacitation
experiments.
1.2.3.3 Western Blot and Immunoprecipitation Assay
Reagents used in sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) and the protein molecular weight marker were purchased from
Bio-Rad (Hercules, CA). The polyvinylidene difluoride (PVDF) membrane was
purchased from EMD Millipore (Billerica, MA). BioMax Light film was purchased from
Carestream Health Care, Inc./Kodak, Rochester, NY. Fish skin gelatin was purchased
from Sigma-Aldrich. Antibodies were purchased as follows: AMPKα poly- and
monoclonal, and anti-PKA from Cell Signaling (Danvers, MA), monoclonal anti-PY
from EMD Millipore (Billerica, MA), and anti-tubulin clone E7 from DSHB. Secondary
antibodies (anti-mouse IgG, anti-rabbit IgG, HRP and High + Light chain) were
purchased from Jackson ImmunoResearch (West Grove, PA). The inhibitors used to
create RIPA+ and PBS+ included NaVO4 (1mM from Sigma), βGP (40mM from Sigma),
and 50X protease inhibitor from Roche.
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C2C12 murine lysates were purchased from Cell Signaling. 293T cells were
grown in-lab in a monolayer and pelleted prior to lysis. Magnetic A-beads and G-beads
were purchased from Millipore (Billerica, MA).
1.2.3.4 Sperm Cell Viability Assay
The Live/Dead® Sperm Viability Kit was purchased from Life Technologies
(Carlsbad, CA) and was prepared as indicated in the manufacturer’s protocol. A HEPESbuffered saline solution was prepared and contained: 10mM HEPES (from Fisher),
150mM NaCl (from Sigma), and 10% BSA at a pH of 7.4.
1.2.3.5 Computer-Assisted Sperm Analysis (CASA)
Mouse sperm cells were loaded into a single side of a 2-chambered 100-micron
slide (Leja, Netherlands). The slide was read using an Olympus CX41 microscope, and
sperm motility data captured by HTR motility software (Equine – Version 14 Build 008
programed for mouse sperm by Hamilton-Thorne/Pyramid Technical Consultants, Inc.).
Data acquisition was programmed at the following settings: Image capture at 60
frames/second at a rate of 60Hz under a 4X objective. The minimum acceptable values
were set at 20% motility, minimum contrast at 35, minimum cell size at 4 pixels,
progressive cells had to have a path velocity (VAP) of 50.0μ/s, a straightness of 50%, and
of the slow cells, a VAP of 10.0μ/s, and a straight line velocity (VSL) of 0.0μ/s. Five
fields were captured in each treatment and the results run through the CASAnova
analysis software developed by Goodson et al. (2011). The data capture files (.DBT) were
imported to Microsoft Excel to observe trends in motility and hyperactivity.
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1.2.4 Aim 2 Methods
1.2.4.1 Protein Extraction
Mice were sacrificed by CO2 followed by cervical dislocation, and the cauda
epididymides removed and cut to allow mouse sperm cells to swim out in NC media for
ten minutes at 37°C. Following swim out, the remaining epididymis tissue debris was
removed from the 2ml-eppendorf (Radnor, PA), and sperm cell suspension split amongst
1.5ml-eppendorf tubes for further treatments if necessary. Cells were then centrifuged for
two minutes at 12500rpm; the supernatant was discarded, leaving the pellet. To wash the
cells and prevent further protein degradation, cold 1X filter sterilized PBS was added to
the pellet. The cells were then centrifuged at 13,400rpm for three minutes to re-pellet
them. The supernatant was discarded and the tubes placed on ice immediately. For cell
lysis, 5X sample buffer was added to the cell pellets. The tubes containing the cell lysates
were boiled for four minutes and centrifuged again for five minutes at 13,400rpm. The
supernatant contained the protein and was transferred to a new tube and saved at -80°C
for future use. For analysis of signaling events by Western Blotting of PY or PKAS,
sperm cell lysates stored at -80°C were used within 24-48h after sample collection.
1.2.4.2 Sperm Capacitation
Following swim out in NC media, sperm was allocated into individual treatment
tubes and exposed to the previously described Cap media for one hour at 37°C.
Typically, the treatments were as follows: NC, Cap, Cap + DMSO (at 1%), Cap + CC @
0.1μM, 1μM, 10μM, 30μM, 50μM, and 100μM. For appropriate exposure to this
inhibitor, cells were pre-incubated in the NC media with the inhibitor for 15 minutes
prior to the introduction of the Cap media.
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1.2.4.3 Compound C
When testing for the effect of CC on sperm, cells were pre-incubated in NC media
and varying concentrations of CC for 15 minutes prior to the addition of Cap media.
Following the addition of Cap media, cells were incubated for an hour to induce sperm
capacitation. Samples were then either preserved via protein extraction, or used for
further experimentation.
1.2.4.4 Western Blot
The protein extracts were thawed, 2-mercaptoethanol (5% βME, from Bio-Rad)
was added to each extract (at 5% of total volume), and boiled at 100°C for three minutes.
Samples were then centrifuged for a short spin at maximum speed and loaded into a
polyacrylamide gel. The gel percentage varied depending upon the type of initial primary
antibody to be applied: AMPK required a 10% gel, and PKA required an 8% gel.
An electrophoresis was performed and the proteins were transferred to 0.45μm PVDF
membrane for 90 minutes (Laemmli 1970).
1.2.4.4.1 Anti-PKA substrates
The membrane was blocked with 5% milk (prepared in 1X T-TBS –TBS
containing 0.1% Tween-20) for an hour at ambient temperature, then incubated with antiPKA substrate (rabbit monoclonal, Cell Signaling) at 1:10,000 prepared in 5% BSA/TTBS 1X overnight at 4°C. The following day, the membrane was washed with 1X T-TBS
and then incubated with anti-rabbit-HRP (GE Healthcare) at 1:10,000 in 5% milk/T-TBS
1X for two hours at room temperature. Again, the membrane was washed and finally the
membrane was developed using ECL Prime (GE Healthcare) and BioMax Light Film.
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1.2.4.4.2 Anti-PY
Following exposure to PKAs, membranes were stripped and re-probed with
another antibody. Stripping solution comprised of 62.5mM Tris-Cl (pH 6.5) and 2% SDS
was combined with βME (0.74% of total volume) and poured on the membrane. The
membrane was incubated at approximately 59°C for 15-30 minutes on a rocker. After
discarding the solution, the blot was rinsed with MilliQ water ten times and then washed
for longer increments with 1X T-TBS to rid the membrane of βME.
To probe with a different primary antibody, the membrane was blocked again;
when using anti-phosphotyrosine (αPY), the membrane was blocked with 20% fish skin
gelatin (Sigma-Aldrich) for one hour at room temperature, incubated with αPY at
1:10,000 in T-PBS 1X (PBS plus 0.1% Tween-20) overnight at 4°C, then washed with TPBS 1X, incubated with anti-mouse-HRP at 1:10,000 prepared in T-PBS 1X for one hour
at room temperature, washed with 1X T-PBS, and lastly, developed using ECL.
1.2.4.4.3 Tubulin
To blot for tubulin antibody, following stripping, the membrane was blocked with
5% milk in 1X T-TBS for one hour at ambient temperature. The primary antibody was
monoclonal E7 at either 1:1000 or 1:5000 in 1% milk in T-TBS 1X overnight at 4°C, the
membrane was washed the next day, then incubated for one hour at room temperature
with anti-mouse-HRP at 1:10,000 in 1% milk in T-TBS 1X. The membrane was washed
for an hour and then developed with ECL.
1.2.4.4.4 AMPKα
When probing for AMPK, either a monoclonal (clone F6) or polyclonal antiAMPKα antibody was used. Typically 2 x 106 mouse sperm cells were loaded per lane.
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Following protein transfer onto a PDVF membrane, the blot was blocked with 5% non-fat
milk in T-TBS for one hour at room temperature. The primary antibody was suspended in
a 1% milk solution at a concentration of 1:1000. The subsequent day, the membrane was
washed with T-TBS. The secondary antibody was applied –the monoclonal primary
antibody required anti-mouse secondary antibody, while the polyclonal primary antibody
necessitated anti-rabbit –at 1:10,000 in 1% milk and T-TBS. The membrane was washed
for a few short washes in T-TBS and the membrane was developed using ECL.
1.2.4.5 Immunoprecipitation
Sperm samples for immunoprecipitation were prepared in NC media and the
entire swim out of sperm cells from one mouse was pelleted and the supernatant
discarded. Performed on ice, RIPA+ the inhibitors NaVO4 (1mM), βGP (40mM), and
50X protease inhibitor was prepared and added directly to the pellet of cells. For cell
lysis, the tube with the cells was incubated for 15 minutes on ice and vortexed every five
minutes; it was then centrifuged for five minutes at 4°C at 3000rpm.
The supernatant was separated from the pellet. Add 10% SDS to the RIPA+
solution at a concentration of 0.5%. This new solution was added to the remaining pellet,
to proceed with a sequential protein extraction for sperm cells. Incubation on ice and
vortexing every five minutes was repeated for a total of 15 minutes. It was centrifuged
again for five minutes at 4°C at 3000rpm and the supernatant was pooled with the
previous supernatant. A pre-determined volume (based on the number of cells desired per
well) was removed and put into a separate tube (this was an “input” sample; the other
portion was used for immunoprecipitation). To the IP samples, PBS+ inhibitors were
added to ensure not more than 0.1% of SDS in final IP reaction; anti-AMPK-alpha was
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added at 1:100 (or tubulin (monoclonal E7) at 1:500 in control IP). These tubes were
incubated on a rotator at 4°C for 1.5 hours.
During incubation, an equal combination of A-beads and G-beads were prepared
via washing with cold PBS + 0.1% Tween-20 (Sigma-Aldrich) and then the supernatant
removed and the tubes put on ice. After incubation on the rotator, the tubes were spun
down and the supernatant, containing the AMPK-Ab complexes, transferred to the tubes
containing the beads, and the reaction was mixed. The tubes were put back into the cold
rotator for an additional two hours.
Using a magnetic rack, the beads were washed three times and the supernatant
discarded. New tubes were prepared with βME while 2X sample buffer was added to the
beads and vortexed. Tubes were then boiled for ten minutes, vortexed, and spun down at
13,400rpm for one minute. The supernatant was removed and put into the tubes
containing βME, leaving the beads behind. These samples were stored at -20°C until their
use the next day.
1.2.4.6 CASA
After the hour of capacitation (as described above), 20μl of sample (equivalent to
approximately 2-4 x 105 cells) were removed from the middle of each tube and put into a
single slide’s chamber. CASA/CASAnova then analyzed samples.
1.2.4.7 Acrosome Reaction
After an hour of incubation in capacitating medium, the calcium-ionophore
(A23187) (Sigma-Aldrich) was added at a concentration of 10μM/reaction. Samples were
incubated for another 30 minutes at 37°C. Parallel samples without A23187 were
processed for assessment of spontaneous AR. In addition, samples were collected after a
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very brief incubation of sperm samples in Cap medium (considered time zero, T0) and
taken as AR controls.
1.2.4.8 PNA Fluorescence Imaging
Following the induction of the acrosome reaction, one milliliter of 4%
paraformaldehyde (PF) (Fisher, Framingham, MA) was added to each treatment and
samples incubated for ten minutes at room temperature to fix the cells in solution. To
remove the PF, tubes containing the samples were centrifuged at 2,500rpm for five
minutes, the supernatant discarded, a milliliter of 1X PBS added, centrifuged again at
2,500rpm for five minutes, the supernatant discarded, and the pellet resuspended in 200μl
1X PBS.
Using a wide-bore pipet tip (VWR), a 25μl droplet of each sample was put onto
clean slides (Gold Seal Rite-On Micro Slides, Portsmouth, NH) and allowed to air-dry for
5-10 minutes. To permeabilize the cells, 20μl of 100% Methanol (Fisher) was added to
each droplet for 30 seconds then aspirated. To ensure the remaining methanol was
removed, the slides were washed with 20μl of 1X PBS for one minute each, then the PBS
was aspirated; this was performed three times. To detect the cell’s acrosomal region, 20μl
of FITC-PNA (prepared at 1:50 from stock, from Molecular Probes Eugene, OR) was
applied to each treatment; the slides were then incubated for 30 minutes in a dark
chamber.
Again, the cells were exposed to a series of washes and aspirations with 1X PBS.
A mounting media comprised of glycerol:PBS (9:1) (glycerol from Fisher) was applied to
each treatment (4μl) and a clean coverslip (Corning, No. 1.5 from Tewksbury, MA) was
applied to each slide. Using a fine pair of forceps, the coverslip was lightly pressed into

15

the slide to ensure even coverage of the mounting media throughout the treatment. The
slides were then sealed with nail polish and stored at 4°C in a dark chamber. Cell
counting and AR assessment was performed within 24h.
Slides were read and visually quantified via differential interface contrast (DIC)
and fluorescent microscopy using a Nikon Eclipse TE300 and a 60X objective. The
camera was an Andor/Zyla and the software used was NIS Elements.
1.2.4.9 Viability
To monitor the viability of sperm cells, especially following the addition of CC,
the Life Technologies Live/Dead® Sperm Viability kit was utilized. Reagents were
prepared as indicated in the protocol. Following capacitation, a small volume from each
treated sample was put into a separate tube (approximately 1-2 x 106 sperm cells were
removed per sample for viability testing). The prepared SYBR 14 (in kit) was added to
the new tube at 100nM and incubated for five minutes at 37°C; the propidium iodine (PI)
was added at 12μM and incubated at 37°C for an additional five minutes. To wash away
the excess PI, the tubes were centrifuged for five minutes at 2,500rpm and the
supernatant discarded; 500μl of HEPES buffer was added to each tube. The samples were
centrifuged again at the same speed, and for the same duration, and the supernatant was
discarded. Pellets were resuspended in approximately 200μl of HEPES buffer and were
mounted to slides and visually quantified using the same technique described in the
fluorescent imaging section (paragraph 1.2.3.2.8). By staining with two unique reagents,
the viability status of each cell was determined. SYBR 14 is a small, membranepermeable molecule that can enter sperm cell nuclei and produce a green signal under
fluorescent imaging. PI is excluded from viable cells and is a known membrane-
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impermeant dye; however, when a cell dies or its structure is seriously damaged, their
nuclear pores expand, allowing for PI to enter. A red signal is emitted under fluorescent
microscopy (Garner and Johnson 1995).
1.2.4.10 In Vitro Fertilization (IVF)
In vitro fertilization was performed over 4-5 days beginning by injecting the
female mice intra-abdominally with 5IU with pregnant mare’s serum gonadotropin
(PMSG from Sigma) (Day 1) to induce superovulation. Thirteen hours prior to sacrifice
(evening of Day 3), females were injected intra-abdominally with human chorionic
gonadotropin (hCG, from Sigma); IVF media was also prepared on Day 3. Capacitating
TYH media was prepared and 500μl of media was put into well plates (Thermo Scientific
nunclon surface). The well plate and remaining Cap media were placed in a 37°C CO2
incubator (5.1% CO2) with a loose lid for appropriate O2/CO2 exchange.
The following morning (Day 4), a single male mouse was sacrificed and the
sperm was allowed to swim out in NC media for ten minutes. The sperm was preincubated with the CC (30μM or 100μM) or H89 (50μM) inhibitors followed
centrifugation at 2,500rpm for five minutes. The supernatant was discarded and the pellet
was resuspended in Cap media. The remaining inhibitor was added to bring it up to the
appropriate concentration and the whole sample was transferred to a 2-ml tube.
Capacitation was allowed to occur over the next hour and a half in the CO2 incubator.
While the sperm was undergoing capacitation, the female mice were sacrificed.
The reproductive tracts of the females were removed and put into warmed M2 media.
Using a fine pair of forceps, the oviducts were punctured to release the cumulus/oocyte
complex. The complex was carefully transferred to a separate, fresh dish of M2 media
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using a glass mouth pipet in order to separate the complex from the reproductive tract.
The oocytes were then transferred to the IVF well plates.
When the sperm was capacitated, 10μl of sperm was added to the well plates
containing the oocytes. Inhibitors were added to the wells (if necessary) and the entire
plate was incubated for four hours in the CO2 incubator. After that time period, oocytes
were washed and returned to the incubator for approximately 20 hours. The next day
(Day 5), oocytes were observed under the Nikon microscope at 20X and 60X
magnification. Oocytes were quantified as 2-cell, 1-cell, or degraded embryos. IVF was
also double-checked on Day 5.
1.2.4.11 Statistical Analysis
For all quantified data in Chapter 3, Analysis of Variance (ANOVA) was used for
statistical analysis. In most cases, the data (percentages) were transformed to comply with
the assumptions necessary for ANOVA analysis. Post-test comparisons were made using
the Tukey-Kramer test or Fisher test to determine p-values.
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CHAPTER 2
IN VITRO SCREENING FOR SMALL-MOLECULE KINASE INHIBITORS OF TESTIS-SPECIFIC
SERINE KINASE 1 (TSSK1)
2.1 Rationale
TSSKs are a unique family of serine/threonine kinases localized to the testes; the
conserved expression of TSSK genes and well-established role of phosphorylation of
sperm proteins suggests that TSSKs have a role in sperm function (Hao, Jha et al. 2004,
Li, Sosnik et al. 2011). TSSK1 was the first described member of the TSSK family
(Bielke, Blaschke et al. 1994) and it was found in both an active and inactive state.
Members of the TSSK family are typically considered “active” when they are
phosphorylated; phosphorylation of the hydroxyl group of either the threonine or serine
residue within the T-loop using ATP as the phosphate donor activates the kinase.
According to ex vivo work performed by Bucko-Justyna, there is evidence of TSSK
autophosphorylation (Bucko-Justyna, Lipinski et al. 2005, Xu, Hao et al. 2008), which
would suggest that the kinase has the ability to self-activate. The goal of our lab is to find
a small-molecule inhibitor that is specific to TSSK1. Since our group found TSSK1 to be
the most soluble when analyzed in mouse and human sperm samples (Li et al., 2011), and
it would prove more amenable to biochemical characterization in vivo and in vitro,
TSSK1 was chosen as the model target for the search of a kinase inhibitor.
In order to progress to high throughput screening (HTS), there are a number of
steps necessary to perform prior. Based on the steps outlined by Brooks (Brooks 2012)
among others, it is necessary to define reagents and instruments, validate the assay, and
optimize conditions before engaging in HTS. The following experiments were designed
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to (a) determine assay feasibility, (b) establish experimental parameters, and (c) begin to
look at a reduced battery of kinase of potential inhibitors as a method to assess the (d)
sensitivity of a homogeneous TSSK1 activity assay in a small scale system, which could
then by adapted to an HTS of a larger library of compounds.
2.2 Results
2.2.1 Testing Assay Sensitivity
As shown in Figure 9, the feasibility of using the ADP-Glo™ kit was tested using
recombinant purified TSSK1 (rTSSK1). Using the substrate myelin basic protein peptide
(MBPp) and ATP, rTSSK1 kinase reactions were performed in a 96-well plate assay to
determine whether the ADP-GLO detection system was effective for quantifying TSSK1
kinase activity in vitro. Prior to running the assay, the possibility of TSSK1
autophosphorylation was acknowledged (Bucko-Justyna, Lipinski et al. 2005, Xu, Hao et
al. 2008); to investigate the rate of autophosphorylation, rTSSK1 was put through the
ADP-Glo™ assay without a substrate, alongside treatments that included substrate –in
this case, MBPp. While there was a noticeable amount of autophosphorylation in the
rTSSK1 at 25ng and 50ng, what was more significant was that when utilizing as low as
25ng of rTSSK1 in a 96-well plate reaction, rTSSK1 activity could be detected in
comparison to reactions containing ATP alone (control). In addition, there was a dosedependent response to the amount of kinase used; the kinase activity at 50ng of rTSSK1
was nearly double that of 25ng. Of equal importance was that the experiment
demonstrated that the assay was functional using this kinase, and kinase activity was
detectable at the lower concentration. As a result of this series of experiments, it was
determined that rTSSK1 at 25ng could be used for future assays.
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2.2.2 Testing Substrate Sensitivity
To continue establishing assay parameters, it was necessary to identify the most
appropriate substrate. Our lab had demonstrated that MBPp was a suitable substrate for
TSSKs, due to positive published data from radioactive assays utilizing TSSK1 and
TSSK2, and also based on studies by others (Bucko-Justyna, Lipinski et al. 2005).
However, more recent literature indicated that the peptide, AMARA, could also be a
suitable substrate for use with TSSKs (Jaleel, McBride et al. 2005), SIK, and AMPK
kinases (TSSKs are members of the AMPK branch of the kinome). To determine which
of the two substrates, MBPp or AMARA, was more sensitive to phosphorylation by
TSSK, an assay was designed to compare the two substrates (Fig. 10). Both substrates
were tested at various concentrations from 0-100μM to compare the relative
luminescence units (RLU) output. From the resulting graph, significant differences
between the RLU outputs of the two substrates can be seen. This experiment indicated
that AMARA was more sensitive and likely more specific to rTSSK1, showing a nearly
10-fold increase of RLU output versus MBPp. Further assays were performed using
AMARA as the substrate.
2.2.3 rTSSK1 Concentration Curve
Following the previous determinations and because ultimately, the overall
endpoint was to bring this assay to HTS, investigation into the suitability and
functionality of the assay at lower concentrations was the next step. To do so, ATP and
AMARA were both added at 100μM to a 384-well plate and rTSSK1 was scaled-down to
concentrations ranging from 0-18.25ng per reaction, specifically chosen to lower amounts
than previous assays in order to test sensitivity. As shown in Figure 11, we were able
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detect changes in TSSK1 kinase activity at concentrations as low as 2.5ng in a 384-well
plate format. Until this point, all assays were performed in a 96-well plate with a total
reaction volume of 100μl; with this new information, we were able to reduce the total
reaction volume by using smaller reagent volumes. Subsequent assays were performed in
a 384-well plate with a total reaction volume of 25μl. The possibility of quantity
reduction was necessary for HTS, and this particular experiment encouraged continuation
of work with this particular assay on this specific kinase.
2.2.4 Testing rTSSK1 Inhibition In Vitro
As stated previously, the goal of this series of experiments was to look for
inhibitors of TSSK1. Using the assay parameters established above, an assay was
performed that incorporated a battery of known kinase inhibitors, including spermspecific targets such as PKA or Src. Some inhibitors were broad spectrum, such as
Staurosporine that inhibits several protein kinases, whereas others were more specific,
inhibiting PKA or AMPK. Listed in the table in Figure 12 are the inhibitors used, listed in
order of increasing selectivity: from the most broad-spectrum to the more specific
inhibiting reagents. To each reaction, a different inhibitor at 100μM or DMSO (control)
was added alongside rTSSK1 and AMARA. The corresponding RLU output was graphed
in Fig. 12; based on the graph it can be seen that CC and SKI 606 were the most effective
compounds to inhibit rTSSK1. Further investigation of CC was performed – because it is
an AMPK inhibitor, and TSSKs are found on the AMPK branch, it was hypothesized that
CC might be a suitable inhibitor of TSSKs.
Figure 13 depicts the inhibitory effect of CC on rTSSK1 at concentrations from
0.1μM-100μM. The downward curve indicated a dose-dependent effect of CC on
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rTSSK1. Beginning at ~25-30μM, there was a significant drop in RLUs, suggesting a
more significant inhibitory effect on rTSSK1 activity.
In summary, the abovementioned series of experiments provided a strong
rationale and some tools for further experimentation with CC by evaluating sperm
functional parameters using and in vivo mouse model.
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CHAPTER 3
IN VIVO TESTING OF SMALL-MOLECULE KINASE INHIBITORS OF AMPK/TSSK
3.1 Rationale
Following investigation of Compound C (CC) and its inhibitory effect on rTSSK1
activity in vitro, the next step was to look at CC in an in vivo model system. Based on the
proven relevance of these endpoints in evaluating sperm function in mice and other
species, we decided to look at the effect of CC on (a) sperm signaling events via
phosphorylation; (b) sperm motility; (c) the occurrence of acrosome reaction, and (d) its
effect on fertilization ability in vitro.
Thus far, there is no clear evidence regarding the role of AMPK in mouse sperm.
Due to this information, the findings from Aim 1 of this Thesis (specifically Figures 11
and 12), and the fact that Compound C is a known AMPK inhibitor, we considered it
very relevant to (a) determine whether AMPK is in fact present in mouse sperm; and (b)
study the effect of a known inhibitor of the AMPK superfamily on mouse sperm function.
Among the possible outcomes expected from studies presented in Aim 2 is that AMPK is
absent in mouse sperm and thus mouse TSSK1might be the main kinase target of
inhibition by CC.
The importance of studying the effects of CC on PKA and PY are due to the role
the two events play in capacitation, and motility. Referring to Figure 3, phosphorylation
of PKA substrates is an indication of capacitation (Aitken, Paterson et al. 1995, de
Lamirande, Leclerc et al. 1997, Leclerc, de Lamirande et al. 1997, Visconti, Johnson et
al. 1997, Breitbart and Naor 1999). We were interested in the effects of CC on
capacitation; towards this goal, we investigated PKA substrate phosphorylation when
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samples were exposed to CC. While it is not well understood what events occur between
PKA substrate phosphorylation and tyrosine phosphorylation (PY), it is known that PY is
downstream of PKA in the cellular pathway. In an attempt to orient TSSKs within the
pathway, we looked at the effects of CC on both PKA substrates and PY.
As described previously, prior to fertilization the sperm must undergo the
acrosome reaction (Dan 1952, Barros, Bedford et al. 1967). It was crucial to investigate
the effects of CC on the acrosome reaction, as the AR is critical to successful
fertilization. Most of our analysis focused on the effect of CC on sperm spontaneous AR;
in some cases, CC effect was also assessed after AR was induced using a calcium
ionophore per Wertheimer (and references therein) (Wertheimer, Krapf et al. 2013). A
visualization of the methodology used for these experiments can be found in Figure 6. It
is worth noting that the Live/Dead® Sperm Viability Kit was consistently run in parallel
to ensure that CC was only affecting AR or motility, not viability (data not shown).
In order for a sperm to reach and then fertilize an egg, it must be not only motile,
but must have reached a hyperactivated state. First suggested by Yanagimachi, sperm
experience a change in motility before fertilization of the oocyte, termed hyperactivation
(Yanagimachi 1981, Suarez, Katz et al. 1983, de Lamirande, Leclerc et al. 1997).
Hyperactivation is characterized by an increase in rapid movement creating a frantic,
increased amplitude and beat frequency of flagellar waves creating a whiplash motion,
and increased lateral head displacement (Mortimer and Mortimer 1990, de Lamirande,
Leclerc et al. 1997). Utilizing these parameters, we applied a computerized system to
measure, quantify, and categorize sperm; this system is known as Computer-Assisted
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Sperm Analysis (CASA). We took advantage of this system to determine the effects of
CC on sperm motility and hyperactivity.
The ultimate test of CC’s efficacy on sperm’s ability to fertilize was to perform an
in vitro fertilization (IVF) experiment. Experiments were designed to allow observation
of the effect of CC on sperm (a), on oocytes (b), and on sperm and oocytes together (c).
3.2 Results – Aim 2.1
3.2.1 Investigation of AMPK in Murine Sperm
To investigate the presence of AMPK in mouse sperm, an initial test by Western
blotting was performed on pelleted CD1 mouse cells. Protein was extracted under
varying conditions of detergent stringency: Triton, RIPA, and SDS. The increasing
stringency of extraction was to ensure all parts of the sperm were broken down and the
protein extracted. Approximately 2 x 106 cells were loaded per lane. Western analyses
blot were run using a polyclonal AMPK antibody at a concentration of 1:1000. AMPK
predicted molecular weight (MW) in somatic cells is ~62kDa. HEK293T cells (human
embryonic kidney cells, a cell line known to contain AMPK) were included to validate
the antibody, and a total cell extract from murine C2C12 cell (myoblasts) was also used
to validate this antibody to recognize AMPK in mouse cells. According to this initial test,
AMPK was not detected in mouse sperm (data not shown). In order to confirm these
results, two distinct western blots were performed next; three individual mice were
sacrificed and their sperm extracted under SDS conditions. Roughly 2 x 106 mouse sperm
cells were loaded per lane in each gel; in parallel, 7.5 x 104 293T cells were loaded as
positive control. One blot was probed using a monoclonal AMPK-α antibody (clone E6,
Fig. 14a) also at a concentration of 1:1000 while the other was probed with the polyclonal
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AMPK-α at the same concentration (blot not shown). As the Western blot in Figure 14(a)
indicates, the monoclonal antibody recognized AMPK in both positive controls, human
and mouse cells, at the expected MW of 62kDa. However, and despite a long exposure
prior to film developing, AMPK was nearly undetectable in mouse sperm samples even
when a monoclonal antibody is utilized.
In order to further assess these findings, AMPK immunoprecipitations were
performed, followed by Western blotting using C2C12 lysate as a positive control, and
293T cells as a secondary biological control; in some cases, IP reactions for AMPK from
293T were carried out in parallel. Each IP sample had an accompanying input sample.
For 293T cells, a RIPA-soluble extract was prepared and about 7.5 x 104 cells were
loaded per lane; the IP sample contained ~4 x 106 cells. To each lane, approximately 1.5
x 106 of mouse sperm cells were loaded as murine RIPA-extracted input samples while
~2.5 x 107 mouse sperm cells were loaded as IP samples.. Although this experiment was
run multiple times using both a monoclonal and a polyclonal antibody (both at 1:100), as
well as with secondary antibodies against either immunoglobulin light chain (L) only or
high and light (H+L) chains together, AMPK was not detectable in mouse sperm under
the several experimental conditions tested. Figures 14 (c & d) are representative of what
was found most often throughout multiple experiments. The Western blot performed
using monoclonal antibody suggested that there may be barely-detectable amounts of
AMPK in mouse sperm, but IP blots suggest that AMPK may not be in mouse sperm, at
least not consistently in all mouse sperm samples analyzed. In very few cases, it could
only be detected when sperm was highly concentrated and/or at high exposure times prior
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to developing, implying that there may only be small amounts, if any, of AMPK present
in mouse sperm.
3.3 Results – Aim 2.2
3.3.1 Effect of Compound C on Sperm Signaling Events
Regardless of whether or not AMPK was present in mouse sperm, it was
necessary to discern if CC effected sperm signaling. Utilizing the pathway in Figure 3 as
a model, it was essential to investigate the two primary areas of the pathway that could be
affected: PKA-dependent phosphorylation and tyrosine phosphorylation (PY) events. It
has been well established that phosphorylation of PKA substrates is indicative of the
activation of this known pathway following upstream events (bicarbonate-dependent
activation of soluble adenylate cyclase, cAMP, and then PKA) (Visconti, Moore et al.
1995, Muratori, Luconi et al. 2009, Visconti 2009). Downstream of PKA is tyrosine
phosphorylation. PY signaling is indicative of whether or not sperm have achieved a
capacitated state (Visconti, Bailey et al. 1995). The two signaling events act as a point of
reference within the sperm signaling pathways, thus allowing for a rational evaluation of
TSSK1 in the signaling events conducive to sperm capacitation and fertilizing ability. In
this Aim, the effect of Compound C on these signaling cascades was analyzed.
Looking at signaling trends, rather than for a specific band, from the PKA
substrate blot (Fig. 15a) it can be seen that there was no significant change in PKA signal
strength even as the concentration of CC increased from 1μM to 100μM. The lower blot
(Fig. 15b), PY, showed a different trend than the PKA blot; as concentrations of CC
increased, PY signaling decreased, indicating a dose-dependent inhibitory response.
While there are clear differences between the controls –Cap shows a darker signal

41

(indicative of successful capacitation) than non-cap (where almost no signal is detected),
the DMSO-treated sample appears to produce similar signaling as the Cap, but starting
around 10μM, a significant decrease in signaling can be observed. Based on these results,
the signaling trend suggested that CC was acting on a target(s) probably downstream of
PKA but upstream of PY. Figure 15c is the phosphorylated hexokinase. In murine sperm
PY blots, the phosphorylated hexokinase may be used as an internal loading control as it
is constitutively phosphorylated on tyrosine (Asquith, Baleato et al. 2004).
3.3.2 Computer-Assisted Sperm Analysis
Using the CASA system described in Figure 16, total motility and hyperactivity
of sperm (average) was evaluated when sperm were exposed to CC at varying
concentrations. Both Cap and Cap + DMSO (at 1%) were used controls, providing a
baseline with which to compare the CC-treated cells. As per the parameters outlined by
Goodson et al. (2011) based on the kinematics described by WHO (2010), sperm
underwent capacitation and were subjected to CC treatments; 20μl of sample containing
approximately 2-4 x 105 mouse sperm cells were then removed from the experimental
tubes and introduced to the 2-chambered slides for data capturing and analysis. From the
CASAnova analysis, the total number of motile sperm was calculated for each treatment.
The average of sperm motility and hyperactivation acquired from several experiments
(N>4) was calculated, and Figure 16 shows the resulting bar graph. The results were
analyzed using ANOVA to calculate significant variance; post transformation, data
underwent the Tukey test. The resulting motility of sperm exposed to CC at either 50μM
or 100μM was significantly less than that of the controls (compared against the Cap
control). From those motile cells, the average number of hyperactive cells was calculated
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using the CASAnova software. The lower graph of Figure 16 displays these results; again
the numbers were analyzed using ANOVA and post-test Turkey test. From the graph, it
can be seen that there was a significant decrease in hyperactive sperm when exposed to
30μM or higher concentrations of Compound C.
One area that had yet to be explored was whether the effect of CC on sperm
motility was reversible. According to numerous sources, the inhibitor should be
reversible (Hurtado de Llera, Martin-Hidalgo et al. 2012, Liu, Chhipa et al. 2014);
however, under the couple of experimental conditions we tried in the current study (data
not shown), it was not feasible to reverse the effects of the inhibitor. Replicates of the
following experiments were tried: following capacitation with exposure to CC, a 10% of
the sample was removed and put into fresh Cap media without CC and then incubated for
another hour. After the hour of incubation, 20μl was inspected using CASA. Two
challenges arose due to this experimental design: there were not enough sperm cells to
analyze, and none of the sperm was moving, even at low concentrations of the inhibitor,
indicating that serial dilution was an ineffective method of reducing the concentration of
CC in the media. The second method attempted included a centrifugation and wash using
Cap media following incubation with CC and capacitation. This wash method was more
successful than that of serial dilution, but even after allowing the sperm to incubate in the
clean media for four hours beyond capacitation (with CASA analysis or video
microscopy at 20x magnification every 30-60 minutes) there was no significant
movement or indication of recovered motility. However, in the videos taken some sperm
cells displayed a “shivering” motion. Due to this “shiver,” I wondered whether or not the
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sperm undergo a type of paralysis, however there is no evidence in the sperm/CC
literature that would support this thought.
3.3.3 Compound C and the Acrosome Reaction
Next, in Figure 17 we looked at the effects of CC on the AR. The controls included Cap
samples, and Cap + DMSO (at 1%), both with and without ionophore; this ensured that
the ionophore was functioning properly while acting as an experimental control for
comparison, and to control for the ionophore effect. Using fluorescent FITC-PNA
staining (as per the protocol in Fig. 6) and DIC/green channel (‘GFP filter’) microscopy,
the number of acrosome-reacted versus unreacted cells was quantified as per Yoshida
(Yoshida, Ito et al. 2010). Looking at the upper panel in Fig. 16, the control Cap cells
(without ionophore) displays numerous intact acrosomes –the green slivers indicated by
PNA staining under the GFP filter are the intact acrosomes of individual mouse sperm
cells. The merged overlay and the region of interest (ROI) give clear images of fully
intact acrosomes and initial stages of the AR. From this panel, it can also be seen that
very few (approximately two cells in this image) have already undergone the AR
(indicated by the lack of GFP in the acrosome). This was considered “spontaneous
acrosome-reacted” sperm. Upon treatment with CC, there is a significant decrease in
PNA staining; the merged overlay and ROI are a visual representation of acrosomereacted spermatozoa. Although it was anticipated that CC could inhibit the AR as
concentrations increased, the opposite effect occurred as is evident in Fig. 16 (bar graph).
Instead of inhibiting the AR, CC seems to have had the same or a similar effect as would
a calcium ionophore, suggesting that the inhibitor is actually acting upon a kinase
involved in induction of mouse sperm AR. The data shown is of treatments in Cap
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conditions but without an ionophore (except in the indicated treatment, bar on far right).
The bar graph also provides a few other important pieces of data: T=0 is the spontaneous
AR; ~55% of sperm undergo spontaneous AR in average among several experiments
performed (which is also consistent with published observation by other authors).
Interestingly, CC at concentrations ≥10μM display similar rates of AR in comparison to
the Cap with ionophore treated sample. ANOVA statistical analysis was performed and a
post-test Fisher analysis was performed to compare the data against the T=0 result. From
this analysis, all treatments with CC and the ionophore are statistically significant
compared to T=0. Viability was run in parallel (data not shown) using the Live/Dead®
Sperm Viability kit to ensure CC was not affecting sperm viability.
3.3.4 In Vitro Fertilization
Finally, to test the effect of CC on the sperm’s ability to fertilize, in vitro
fertilization (IVF) was performed. Using a slightly different experimental design than in
previous experiments, a range of treatments was performed to test a few different
possible scenarios. Firstly, a 1x TYH capacitating medium containing BSA (4mg/ml) and
HCO3- (15mM) was prepared. This capacitating media was prepared 13 hours prior to use
and was kept in a CO2 incubator at 37°C to allow appropriate CO2 exchange. The day of
the experiment, mTYH NC media was prepared. Experimental treatments were as
follows: Capacitating media plus DMSO (at 1%), sperm pre-incubated in TYH Cap
media with 30μM CC or 100μM of CC, oocytes pre-incubated with 100μM CC, sperm
pre-incubated with H89 at 50μM, and sperm not only pre-incubated with 100μM of CC,
but also co-incubated – meaning that CC was added to the dish containing both the sperm
and oocytes for a final concentration of 100μM CC maintained throughout the entire
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experiment. Of equal importance to this experiment was that with sperm cells (or
oocytes) considered “pre-incubated,” they underwent a wash using their respective
medium prior to incubation with oocytes (or sperm) in order to minimize carry-over of
CC persisting in the experimental environment. After initiation of the sperm-oocytes coincubation, the dishes were kept in the CO2 incubator at 37°C; four hours later, the
oocyte/cumulus complex was washed and further incubated for an additional 16-20
hours. The next day, the oocytes were examined at 60X magnification and the number of
1-cell and 2-cell oocytes was counted. Figure 18 shows images representative of the
majority of fertilization stages (or the lack thereof) seen following incubation. The
DMSO-treated sperm (control) typically incurred high rates of fertilization, as depicted
by embryos in the 2-cell stage (Fig. 18a). Oocytes incubated with sperm exposed to CC at
30μM showed 2-celled embryos (18b), but only 1-celled oocytes at 100μM (18c). It was
interesting that in Figure 18(d) the concentration of cumulus cells surrounding the oocyte
was very high. According to the literature, cumulus cells contain AMPK (Santiquet,
Sasseville et al. 2014); CC inhibited the cumulus expansion normally experienced by
cumulus cells prior to fertilization. Without cumulus expansion, the sperm are unable to
reach the oocyte. Figure 18e demonstrates that even though the oocytes were exposed to
CC, the washing step in the protocol decreases the concentration of CC enough to allow
for cumulus expansion and occasional fertilization. The negative control, sperm preincubated with H89, a known PKA inhibitor, showed a low number of fertilized cells, as
expected (18f).
As described, the number of 1-cell and 2-cell oocytes was quantified. Oocytes in
the 1-cell stage were considered unfertilized and those in the 2-cell stage were
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categorized as fertilized. In some instances oocytes were considered “degraded” and were
put into the “unfertilized” category as they were unable to be fertilized due to oocyte
deformation. The averages of three experiments are expressed in the accompanying graph
in Figure 18. The graph indicates successful fertilization of oocytes with DMSO-treated
sperm cells (positive control), and a significantly low amount of fertilized oocytes in
sperm cells incubated in H89 (negative control). At the lower concentration of CC, some
oocytes were fertilized; at higher concentrations and when co-incubated with CC, almost
no oocytes were fertilized. When oocytes were pre-incubated with CC, there was some
fertilization, significantly higher than when the sperm was pre-incubated, but less than
the control and when sperm was pre-incubated at 30μM. It is likely that when the oocytes
were washed following pre-incubation, the concentration of CC remaining with the
cumulus cells and oocytes was diminished to a level that would allow sperm to fertilize
the oocytes. To determine statistical significance of fertilization rates, the data was tested
using ANOVA, followed by the Tukey’s test.
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CHAPTER 4
CONCLUSIONS, DISCUSSION, & FUTURE DIRECTIONS
4.1 Conclusions & Discussion
The major finding of the in vitro studies performed for this Thesis is that the
ADP-Glo™ assay is indeed suitable for use with our kinase of interest, TSSK1, even at
low concentrations, making the feasibility of HTS and the possibility of screening a few
thousand inhibitors against TSSK1 a certainty. As mentioned previously, the details
outlined by Brooks, among others, indicate the numerous steps that must be taken prior to
HTS to optimize the chances of finding the desired outcome – which in this case is a
TSSK1 kinase inhibitor suitable for drug development (Brooks 2012). Based on the
assays performed, nearly all required steps were met: all reagents were acquired,
instrumentation was arranged, the assay concept was corroborated (see initial figures for
this chapter), and the assay itself was optimized and validated.
One of the first steps of narrowing inhibitor choices was undertaken during this
project. By testing the activity of TSSK1 against a variety of inhibitors in our midthroughput screening assay, results indicated significant inhibition in comparison to the
control. As discussed, one such inhibitor showing promise was Compound C (CC).
Although SKI-606 showed a comparable inhibitory effect, since it was a broad kinase
inhibitor of Src and tyrosines, it was agreed that a more specific inhibitor should be
investigated. Besides the evidence the assay provided, the several sources of literature
indicated that CC was a potent, selective, and potentially reversible inhibitor of AMPK
(Zhou, Myers et al. 2001, Hurtado de Llera, Martin-Hidalgo et al. 2012, Liu, Chhipa et al.
2014, Nguyen, Alves et al. 2014).
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One clear observation was that both CC (a known serine/threonine kinase
inhibitor) and SKI-606 (a known tyrosine kinase inhibitor) could be equally inhibiting
TSSK1 activity. This fact, which had been also considered among the expected outcomes
of testing such small battery of inhibitors, indicated that it is highly unlikely that CC was
specific enough for further use in drug design against TSSK1 activity. However, the
study was continued using this kinase inhibitor as a good indicator of potent TSSK1
inhibition in vitro, and paved the way for in vivo studies. Also, because these assays were
conducted prior to performing in vivo work, and because there was no strong evidence in
the literature on the absence or presence of AMPK in mouse sperm, there was no way to
know if CC was inhibiting AMPK or TSSK1. However, data presented here (best
depicted in Figure 13) clearly supports the notion that CC can inhibit TSSK1 in vitro,
even at very low concentrations.
Due to its efficacy in vitro, in vivo assays were pursued, and the CC effect studied
in mature mouse spermatozoa. However, caution was taken when considering the
molecule as an in vivo inhibitor as per warnings found in Liu et al., which stated their
lack of confidence in CC being a selective inhibitor of AMPK. But, because Liu did not
perform in vitro studies on their cell line, it was decided to be a strong rationale for
pursuing our analyses in vivo.
The chief findings of these studies included (a) a very low abundance (if present)
of AMPK in murine sperm; (b) the initial placement of a Compound C-sensitive kinase,
which we hypothesize to be TSSK1, in the sperm biochemical pathway conducive to
capacitation; (c) the effects of CC on sperm motility, viability, and acrosome reaction;
and (d) the effect of CC in the fertilization process. Extensive literature searches were
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performed to look into the presence or absence of AMPK in mouse sperm, although there
is scarce published data on the subject, at least for the mouse model. As discussed in the
Results section, we were able to detect a faint signal that was barely detectable following
a long exposure in a Western blot probed with a monoclonal antibody. To increase the
chances of detecting mouse sperm AMPK –by concentrating the sperm sample –an IP
was performed, and despite multiple attempts with both poly- and monoclonal antibodies
against alpha-AMPK, the catalytic subunit of AMPK, and use of both IgA and IgG beads,
no murine signal was produced on the corresponding Western blot. These findings
indicate that while there may be AMPK present in mouse sperm, it is at an extremely low
concentration, which is in agreement with recent data by another lab using a different set
of antibodies (Tartarin, Guibert et al. 2012). With this new insight, and under the
presupposition that there are likely almost undetectable levels of AMPK in mouse sperm,
the small-molecule inhibitor, CC was investigated in known sperm signaling pathways.
As displayed in Figure 3, there are well-defined biochemical pathways in mature
spermatozoa that are activated during capacitation (Visconti 2009). In our studies, as
shown in Figure 15, a concentration curve of CC did not show any obvious change in the
levels of phosphorylated PKA substrates, typically used as an indicator of PKA
activation. In contrast, PY signaling was impacted. These findings would suggest that
TSSK1 may be signaling upstream of PY, and thus PY-dependent phosphorylation (but
not PKA), would be inhibited by Compound C. Alternatively, although not well
understood at this time, a role for TSSK1 autophosphorylation in this cascade of events
cannot be ruled out. According to early studies by Kueng et al. (1997) and others, and
also based on in vitro data presented in this Thesis (Figure 9), TSSK1 is able to undergo
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autophosphorylation (Kueng, Nikolova et al. 1997, Jaleel, McBride et al. 2005,
Spiridonov, Wong et al. 2005). In this regard, TSSK1 autophosphorylating activity could
be altered by CC, thus affecting signaling events related to sperm capacitation.
The next conclusion was on the effect of Compound C on the occurrence of sperm
spontaneous AR. As discussed in the Introduction section of this Thesis, the current
model proposes that the acrosome reaction occurs when the sperm fuses with the oocyte
and the enzyme-containing pocket is released. In this study the effect of CC increased the
rate of AR. This indicated that instead of inhibiting the AR, some kinase(s) was being
activated upon treatment with CC. It is interesting to note that our results, looking into
the occurrence of spontaneous AR, contradict observations by other authors in boar
sperm: according to the only source we found that investigated the effects of CC on
mammalian sperm AR, the ionophore-induced AR is not affected by CC (Hurtado de
Llera, Martin-Hidalgo et al. 2013). However, another source examined the effects of CC
on oocytes in mice, and found that the AMPK inhibitor produced an opposite effect,
stating that CC “increased the frequency of oocyte activation” (Downs, Ya et al. 2010,
Acton 2012). The findings by Downs, et al. are very informative because although it was
found in a different cell type, they too experienced an opposite effect than predicted. Our
data also shows that the effect of CC on AR can reach levels as high as those found when
AR is induced by a calcium ionophore (Figure 17).
Performing a concentration curve with CC and subjecting the sperm to CASA
analysis showed a severe decline in sperm motility. Consistent with recent studies by
three independent research groups –Hurtado de Llera, Nguyen and Tartarin –who have
investigated the effects of CC on boar, chicken, and mouse spermatozoa, respectively –
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CC has shown inhibitory effects on sperm motility and hyperactivation. Since the present
project also examined viability in parallel to CASA experiments, it was also confirmed
by the aforementioned sources that viability decreased only when exposed to the inhibitor
for either an extended period of time, or to high concentrations (100uM or higher). It is
important to note that an area requiring additional research is the reversibility of CC in
relation to sperm motility. As discussed in the Results section, we performed a series of
tests to address this question; however we were unable to detect clear signs of recovery
on motility in sperm that had been exposed to CC.
The critical final step of evaluating the effect of CC on spermatozoa was to test its
effect on fertilization. Compound C induced significantly decreased rates of fertilization
in mice, similar to the decreased rates of fertilization of Tartarin et al. (Tartarin, Guibert
et al. 2012). This is the true test of inhibitor potency since it is considered the most
relevant functional endpoint to the process of contraceptive development. Thus far, no
other studies have been performed using CC on IVF. It was interesting and somewhat
unexpected that IVF using sperm pre-incubated with 30μM CC was able to fertilize as
much as it did; the CASA data indicated that although there was only ~20% sperm
motility, there was less than 5% of hyperactivity. As discussed previously, sperm must
achieve hyperactivity prior to fertilization. With such low percentages of motile,
hyperactive sperm, it seemed unlikely that many oocytes could have been fertilized.
However our data shows that the opposite may be true. Ideally, additional experiments,
such as using a wider range of CC concentrations, could be performed. IVF tends to be a
costly experiment in terms of time and lab resources, including male and female mice.
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4.2. Future Directions
The remaining steps necessary for commencing HTS using TSSK1 on a larger set
of kinase inhibitors library is beyond the scope of this project. Following the experiments
performed, in the case of our lab, collaborations with the HTS Facility at UMass
Worcester have been recently established to pursue such goal. Leaving aside the financial
aspect that accompanies any project needing to utilize a specialty Facility, inhibitors must
be selected based on the biochemical properties of the intended target. Although there
have been preliminary steps taken toward creation of a biased library of a few thousands
of inhibitors, the protocols are still underway. Additionally, a few biochemical
parameters remain to be determined or calculated for TSSK1, such as the IC50 of the
kinase (one experiment has been performed to generate an approximate calculation, but
more replicates are necessary); establishment of a crystal structure of TSSK1 would be
ideal to have. Our group is currently working on 3-D models of TSSK1, which should
help on a more rationale design of a TSSK1-focused screening of kinase inhibitors by
HTS.
In terms of our in vivo findings, many of the next steps needed for this project lie
within the ability to detect the presence of AMPK in mouse sperm. Additional
experiments should be devised towards detecting the regulatory subunits of AMPK in
sperm, for instance, using antibodies against AMPKβ and/or AMPKγ. Since AMPKα is
the catalytic subunit, it seemed reasonable to test that specific subunit first. However,
since it produced results that may be taken as contradictory, to some degree, when
compared to published data on sperm from other species, testing the other two component
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subunits of the AMPK complex would make for a more complete and thorough
investigation of the presence or absence of AMPK in murine sperm.
To definitively test whether or not PKA is affected by CC, a radioactive kinase
assay should be performed. Using P32 ATP, the activity of PKA’s ability to phosphorylate
the substrate Kemptide under conditions including CC could be quantitatively measured.
Further experiments in the realm of the acrosome reaction should be performed.
As mentioned, the results that CC activated the AR were unexpected; if new experiments
were performed and the results comparable, then it could be confirmed that CC indeed
increases the rate of AR. However, further investigation into the biochemical reasoning
for this occurrence would have to take place as well. Currently there is no evidence as to
why or how this could happen so the biochemical aspect would have to be taken into
consideration. Although it would take a great deal of time to optimize the conditions,
fluorescence activated cell sorting (FACS) is another option for analysis. Once the
parameters were established, FACS would be a way to quickly determine whether or not
a cell had released its acrosome contents and the data could be plotted for analysis.
Additional experiments to investigate whether or not sperm can regain motility
and/or achieve a hyperactive state following exposure to CC would be another area where
more research is needed. Several sources indicate that CC should be a reversible
inhibitor, however our attempts in this area have indicated otherwise. An interesting
experiment to look into this issue would be to perform an IVF experiment and then wash
the oocyte/cumulus cells/sperm cell complex following the 4 hour incubation and see if
replacing the media would allow sperm to regain its fertilization ability.
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In summary, we have been able to further validate the use of a homogeneous
kinase assay to assess TSSK1 activity in vitro, and have found experimental conditions
for screening of large libraries of TSSK1 inhibitors by HTS. Furthermore, we have
applied several functional in vivo assays for validating such inhibitor(s) as potential
blocker(s) of TSSK1 function. In addition, we provide here valuable information on
AMPK being present at very low levels in mouse sperm when compared to data provided
by other authors who have analyzed the role of CC on the AMPK pathway in other
species. Finally, we have documented very important observations on the effect of
Compound C (also known as dorsomorphin or BML-275) on sperm signaling pathways
conducive to its fertilizing ability. Overall, this Thesis provides strong support on TSSK1
as a potential target for development of male contraceptives, as well as several rationale
endpoints for validation of TSSK1 potential inhibitors using both in vitro and in vivo
settings.

60

BIBLIOGRAPHY
Acton, A. Q. (2012). Germ Cells: Advances in Research and Application. Atlanta, GA,
ScholarlyEditions.
Aitken, R. J., M. Paterson, H. Fisher, D. W. Buckingham and M. van Duin (1995).
"Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the
control of human sperm function." J Cell Sci 108 ( Pt 5): 2017-2025.
Asquith, K. L., R. M. Baleato, E. A. McLaughlin, B. Nixon and R. J. Aitken (2004).
"Tyrosine phosphorylation activates surface chaperones facilitating sperm-zona
recognition." J Cell Sci 117(Pt 16): 3645-3657.
Barros, C., J. M. Bedford, L. E. Franklin and C. R. Austin (1967). "Membrane
vesiculation as a feature of the mammalian acrosome reaction." J Cell Biol 34(3): C1-5.
Bielke, W., R. J. Blaschke, G. C. Miescher, G. Zurcher, A. C. Andres and A. Ziemiecki
(1994). "Characterization of a novel murine testis-specific serine/threonine kinase." Gene
139(2): 235-239.
Breitbart, H. and Z. Naor (1999). "Protein kinases in mammalian sperm capacitation and
the acrosome reaction." Rev Reprod 4(3): 151-159.
Brooks, H. B., Geeganage, S., Kahl, S.D., Montrose, C., Sittampalam, S., Smith, M.C.,
Weidner, J. R. (2012). Assay Guidance Manual.
Bucko-Justyna, M., L. Lipinski, B. M. Burgering and L. Trzeciak (2005).
"Characterization of testis-specific serine-threonine kinase 3 and its activation by
phosphoinositide-dependent kinase-1-dependent signalling." FEBS J 272(24): 63106323.
Chang, M. C. (1951). "Fertilizing capacity of spermatozoa deposited into the fallopian
tubes." Nature 168(4277): 697-698.
Control, C. f. D. (2015, Feb. 24, 2015). "Contraception." 2015.
Dan, J. C. (1952). "Studies on the Acrosome. I. Reaction to Egg-Water and Other
Stimuli." Biological Bulletin 103(1): 54-66.
de Lamirande, E., P. Leclerc and C. Gagnon (1997). "Capacitation as a regulatory event
that primes spermatozoa for the acrosome reaction and fertilization." Mol Hum Reprod
3(3): 175-194.
Dorman, E. and D. Bishai (2012). "Demand for male contraception." Expert Rev
Pharmacoecon Outcomes Res 12(5): 605-613.

61

Downs, S. M., R. Ya and C. C. Davis (2010). "Role of AMPK throughout meiotic
maturation in the mouse oocyte: evidence for promotion of polar body formation and
suppression of premature activation." Mol Reprod Dev 77(10): 888-899.
Garner, D. L. and L. A. Johnson (1995). "Viability assessment of mammalian sperm
using SYBR-14 and propidium iodide." Biol Reprod 53(2): 276-284.
Garside, D., Gebril, A., Alsaadi, M., Nimmo, N., Mullen, A., Ferro, V. (2013). "An
Update on the Potential for Male Contraception: Emerging Options." Journal of
Contraception 2013:4: 1-11.
Hao, Z., K. N. Jha, Y. H. Kim, S. Vemuganti, V. A. Westbrook, O. Chertihin, K.
Markgraf, C. J. Flickinger, M. Coppola, J. C. Herr and P. E. Visconti (2004). "Expression
analysis of the human testis-specific serine/threonine kinase (TSSK) homologues. A
TSSK member is present in the equatorial segment of human sperm." Mol Hum Reprod
10(6): 433-444.
Hardie, D. G. (2015). "AMPK: positive and negative regulation, and its role in wholebody energy homeostasis." Curr Opin Cell Biol 33: 1-7.
Hasuwa, H., Y. Muro, M. Ikawa, N. Kato, Y. Tsujimoto and M. Okabe (2010).
"Transgenic mouse sperm that have green acrosome and red mitochondria allow
visualization of sperm and their acrosome reaction in vivo." Exp Anim 59(1): 105-107.
Hurtado de Llera, A., D. Martin-Hidalgo, M. C. Gil, L. J. Garcia-Marin and M. J.
Bragado (2012). "AMP-activated kinase AMPK is expressed in boar spermatozoa and
regulates motility." PLoS One 7(6): e38840.
Hurtado de Llera, A., D. Martin-Hidalgo, J. E. Rodriguez-Gil, M. C. Gil, L. J. GarciaMarin and M. J. Bragado (2013). "AMP-activated kinase, AMPK, is involved in the
maintenance of plasma membrane organization in boar spermatozoa." Biochim Biophys
Acta 1828(9): 2143-2151.
Ikawa, M., S. Yamada, T. Nakanishi and M. Okabe (1999). "Green fluorescent protein
(GFP) as a vital marker in mammals." Curr Top Dev Biol 44: 1-20.
Jaleel, M., A. McBride, J. M. Lizcano, M. Deak, R. Toth, N. A. Morrice and D. R. Alessi
(2005). "Identification of the sucrose non-fermenting related kinase SNRK, as a novel
LKB1 substrate." FEBS Lett 579(6): 1417-1423.
Kogan, P. and M. Wald (2014). "Male contraception: history and development." Urol
Clin North Am 41(1): 145-161.
Kueng, P., Z. Nikolova, V. Djonov, A. Hemphill, V. Rohrbach, D. Boehlen, G. Zuercher,
A. C. Andres and A. Ziemiecki (1997). "A novel family of serine/threonine kinases
participating in spermiogenesis." J Cell Biol 139(7): 1851-1859.

62

Laemmli, U. K. (1970). "Cleavage of structural proteins during the assembly of the head
of bacteriophage T4." Nature 227(5259): 680-685.
Leclerc, P., E. de Lamirande and C. Gagnon (1997). "Regulation of protein-tyrosine
phosphorylation and human sperm capacitation by reactive oxygen derivatives." Free
Radic Biol Med 22(4): 643-656.
Li, Y., J. Sosnik, L. Brassard, M. Reese, N. A. Spiridonov, T. C. Bates, G. R. Johnson, J.
Anguita, P. E. Visconti and A. M. Salicioni (2011). "Expression and localization of five
members of the testis-specific serine kinase (Tssk) family in mouse and human sperm
and testis." Mol Hum Reprod 17(1): 42-56.
Liu, X., R. R. Chhipa, I. Nakano and B. Dasgupta (2014). "The AMPK inhibitor
compound C is a potent AMPK-independent antiglioma agent." Mol Cancer Ther 13(3):
596-605.
Lohiya, N. K., I. Alam, M. Hussain, S. R. Khan and A. S. Ansari (2014). "RISUG: an
intravasal injectable male contraceptive." Indian J Med Res 140 Suppl: S63-72.
Manning, G., D. B. Whyte, R. Martinez, T. Hunter and S. Sudarsanam (2002). "The
protein kinase complement of the human genome." Science 298(5600): 1912-1934.
Mortimer, S. T. and D. Mortimer (1990). "Kinematics of human spermatozoa incubated
under capacitating conditions." J Androl 11(3): 195-203.
Mosher, W. D., J. Jones and J. C. Abma (2012). "Intended and unintended births in the
United States: 1982-2010." Natl Health Stat Report(55): 1-28.
Muratori, M., M. Luconi, S. Marchiani, G. Forti and E. Baldi (2009). "Molecular markers
of human sperm functions." Int J Androl 32(1): 25-45.
Murdoch, F. E. and E. Goldberg (2014). "Male contraception: another Holy Grail."
Bioorg Med Chem Lett 24(2): 419-424.
Nakanishi, T., M. Ikawa, S. Yamada, M. Parvinen, T. Baba, Y. Nishimune and M. Okabe
(1999). "Real-time observation of acrosomal dispersal from mouse sperm using GFP as a
marker protein." FEBS Lett 449(2-3): 277-283.
Nguyen, T. M., S. Alves, I. Grasseau, S. Metayer-Coustard, C. Praud, P. Froment and E.
Blesbois (2014). "Central role of 5'-AMP-activated protein kinase in chicken sperm
functions." Biol Reprod 91(5): 121.
Nieschlag, E. (2010). "Clinical trials in male hormonal contraception." Contraception
82(5): 457-470.
Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi and Y. Nishimune (1997). "'Green
mice' as a source of ubiquitous green cells." FEBS Lett 407(3): 313-319.

63

Salicioni, A. M., Romano, F., and Visconti, P.E. (2012). "Testis-Specific Kinases in Male
Fertility and as Targets for Contraception." American Pharmaceutical Review July/Aug.
2012.
Santiquet, N., M. Sasseville, M. Laforest, C. Guillemette, R. B. Gilchrist and F. J.
Richard (2014). "Activation of 5' adenosine monophosphate-activated protein kinase
blocks cumulus cell expansion through inhibition of protein synthesis during in vitro
maturation in Swine." Biol Reprod 91(2): 51.
Shang, P., W. M. Baarends, J. Hoogerbrugge, M. P. Ooms, W. A. van Cappellen, A. A.
de Jong, G. R. Dohle, H. van Eenennaam, J. A. Gossen and J. A. Grootegoed (2010).
"Functional transformation of the chromatoid body in mouse spermatids requires testisspecific serine/threonine kinases." J Cell Sci 123(Pt 3): 331-339.
Spiridonov, N. A., L. Wong, P. M. Zerfas, M. F. Starost, S. D. Pack, C. P. Paweletz and
G. R. Johnson (2005). "Identification and characterization of SSTK, a serine/threonine
protein kinase essential for male fertility." Mol Cell Biol 25(10): 4250-4261.
Suarez, S. S., D. F. Katz and J. W. Overstreet (1983). "Movement characteristics and
acrosomal status of rabbit spermatozoa recovered at the site and time of fertilization."
Biol Reprod 29(5): 1277-1287.
Tartarin, P., E. Guibert, A. Toure, C. Ouiste, J. Leclerc, N. Sanz, S. Briere, J. L. Dacheux,
B. Delaleu, J. R. McNeilly, A. S. McNeilly, J. P. Brillard, J. Dupont, M. Foretz, B.
Viollet and P. Froment (2012). "Inactivation of AMPKalpha1 induces asthenozoospermia
and alters spermatozoa morphology." Endocrinology 153(7): 3468-3481.
Tateno, H., D. Krapf, T. Hino, C. Sanchez-Cardenas, A. Darszon, R. Yanagimachi and P.
E. Visconti (2013). "Ca2+ ionophore A23187 can make mouse spermatozoa capable of
fertilizing in vitro without activation of cAMP-dependent phosphorylation pathways."
Proc Natl Acad Sci U S A 110(46): 18543-18548.
Ventela, S., M. Mulari, M. Okabe, H. Tanaka, Y. Nishimune, J. Toppari and M. Parvinen
(2000). "Regulation of acrosome formation in mice expressing green fluorescent protein
as a marker." Tissue Cell 32(6): 501-507.
Visconti, P. E. (2009). "Understanding the molecular basis of sperm capacitation through
kinase design." Proc Natl Acad Sci U S A 106(3): 667-668.
Visconti, P. E., J. L. Bailey, G. D. Moore, D. Pan, P. Olds-Clarke and G. S. Kopf (1995).
"Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and
protein tyrosine phosphorylation." Development 121(4): 1129-1137.
Visconti, P. E., L. R. Johnson, M. Oyaski, M. Fornes, S. B. Moss, G. L. Gerton and G. S.
Kopf (1997). "Regulation, localization, and anchoring of protein kinase A subunits
during mouse sperm capacitation." Dev Biol 192(2): 351-363.

64

Visconti, P. E., G. D. Moore, J. L. Bailey, P. Leclerc, S. A. Connors, D. Pan, P. OldsClarke and G. S. Kopf (1995). "Capacitation of mouse spermatozoa. II. Protein tyrosine
phosphorylation and capacitation are regulated by a cAMP-dependent pathway."
Development 121(4): 1139-1150.
Wertheimer, E., D. Krapf, J. L. de la Vega-Beltran, C. Sanchez-Cardenas, F. Navarrete,
D. Haddad, J. Escoffier, A. M. Salicioni, L. R. Levin, J. Buck, J. Mager, A. Darszon and
P. E. Visconti (2013). "Compartmentalization of distinct cAMP signaling pathways in
mammalian sperm." J Biol Chem 288(49): 35307-35320.
Xu, B., Z. Hao, K. N. Jha, Z. Zhang, C. Urekar, L. Digilio, S. Pulido, J. F. Strauss, 3rd, C.
J. Flickinger and J. C. Herr (2008). "Targeted deletion of Tssk1 and 2 causes male
infertility due to haploinsufficiency." Dev Biol 319(2): 211-222.
Yanagimachi, R. (1981). Fertilization and Embryo Development In Vitro: Mechanisms of
Fertilization in Mammals. New York, Springer US.
Yanagimachi, R. (1981). Mechanisms of Fertilization in Mammals. Fertilization and
Embryonic Development In Vitro. New York, Springer US: 81-182.
Yoshida, K., C. Ito, K. Yamatoya, M. Maekawa, Y. Toyama, F. Suzuki-Toyota and K.
Toshimori (2010). "A model of the acrosome reaction progression via the acrosomal
membrane-anchored protein equatorin." Reproduction 139(3): 533-544.
Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T.
Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear and D. E. Moller (2001).
"Role of AMP-activated protein kinase in mechanism of metformin action." J Clin Invest
108(8): 1167-1174.

65

